Showing results (11-20 of 40) with videos related to

Sort By:
Pageof 4
Biomed Research International|November 16, 2020
Increased Cytoplasmic CD138 Expression Is Associated with Aggressive Characteristics in Prostate Cancer and Is an Independent Predictor for Biochemical RecurrenceSimon Kind, Martina Kluth, Claudia Hube-Magg, et al.
Disease Markers|May 8, 2020
Upregulation of Phosphatase 1 Nuclear-Targeting Subunit (PNUTS) Is an Independent Predictor of Poor Prognosis in Prostate CancerAndreas Marx, Andreas M Luebke, Till S Clauditz, et al.
World Journal of Urology|November 21, 2019
Claudin-1 upregulation is associated with favorable tumor features and a reduced risk for biochemical recurrence in ERG-positive prostate cancerSimon Kind, Franziska Büscheck, Doris Höflmayer, et al.
Biomedicines|October 27, 2022
Inhibin Alpha Expression in Human Tumors: A Tissue Microarray Study on 12,212 TumorsSören Weidemann, Nessar Ahmad Noori, Maximilian Lennartz, et al.
Human Pathology|June 8, 2021
Diagnostic and prognostic impact of cytokeratin 19 expression analysis in human tumors: a tissue microarray study of 13,172 tumorsAnne Menz, Rifka Bauer, Martina Kluth, et al.
Pathology, Research and Practice|November 14, 2022
Desmoglein 3 (Dsg3) expression in cancer: A tissue microarray study on 15,869 tumorsFlorian Viehweger, Ahmad Azem, Natalia Gorbokon, et al.
Molecular Medicine (Cambridge, Mass.)|March 8, 2020
Upregulation of the transcription factor TFAP2D is associated with aggressive tumor phenotype in prostate cancer lacking the TMPRSS2:ERG fusionChristoph Fraune, Luisa Harms, Franziska Büscheck, et al.
Molecular Carcinogenesis|September 24, 2019
A shift from membranous and stromal syndecan-1 (CD138) expression to cytoplasmic CD138 expression is associated with poor prognosis in breast cancerSimon Kind, Annika Jaretzke, Franziska Büscheck, et al.
BMC Cancer|October 14, 2019
High-level expression of protein tyrosine phosphatase non-receptor 12 is a strong and independent predictor of poor prognosis in prostate cancerSören A Weidemann, Charlotte Sauer, Andreas M Luebke, et al.
Annals of Diagnostic Pathology|February 10, 2025
Brachyury expression is highly specific for chordoma: A tissue microarray study involving 14,976 cancers from 135 different tumor types and subtypesPiero Caneve, Nina Schraps, Katharina Möller, et al.
Pageof 4